HuGE Literature Finder
Records
1
-
30
| Identification of a high-risk group for brain metastases in non-small cell lung cancer patients. Journal of neuro-oncology 2021 Sep . Cacho-Díaz Bernardo, Cuapaténcatl Laura Denisse, Rodríguez Jose Antonio, Garcilazo-Reyes Ytel Jazmin, Reynoso-Noverón Nancy, Arrieta Osc |
| A phase II study of osimertinib for radiotherapy-naïve CNS metastasis from non-small cell lung cancer: Results for the T790M cohort of the OCEAN study (LOGIK1603/WJOG9116L). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Aug . Yamaguchi Hiroyuki, Wakuda Kazushige, Fukuda Minoru, Kenmotsu Hirotsugu, Mukae Hiroshi, Ito Kentaro, Chibana Kenji, Inoue Kohji, Miura Satoru, Tanaka Kentaro, Ebi Noriyuki, Suetsugu Takayuki, Harada Taishi, Kirita Keisuke, Yokoyama Toshihide, Nakatani Yuki, Yoshimura Kenichi, Nakagawa Kazuhiko, Yamamoto Nobuyuki, Sugio Ken |
| Co-mutations of epidermal growth factor receptor and BRAF in Chinese non-small cell lung cancer patients. Annals of translational medicine 2021 Aug 9 (16): 1321. Peng Panli, Lv Guoli, Hu Jinwei, Wang Kai, Lv Junhong, Guo Ga |
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort. Clinical lung cancer 2021 Aug . Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu |
| Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. Lung cancer (Amsterdam, Netherlands) 2021 Jul 159 66-73. Mondaca Sebastian, Lebow Emily S, Namakydoust Azadeh, Razavi Pedram, Reis-Filho Jorge S, Shen Ronglai, Offin Michael, Tu Hai-Yan, Murciano-Goroff Yonina, Xu Chongrui, Makhnin Alex, Martinez Andres, Pavlakis Nick, Clarke Stephen, Itchins Malinda, Lee Adrian, Rimner Andreas, Gomez Daniel, Rocco Gaetano, Chaft Jamie E, Riely Gregory J, Rudin Charles M, Jones David R, Li Mark, Shaffer Tristan, Hosseini Seyed Ali, Bertucci Caterina, Lim Lee P, Drilon Alexander, Berger Michael F, Benayed Ryma, Arcila Maria E, Isbell James M, Li Bob |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Next-generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non-small cell lung cancer. Cancer medicine 2021 Jun . Zhang Yujun, Xiong Liwen, Xie Fangfang, Zheng Xiaoxuan, Li Ying, Zhu Lei, Sun Jiayu |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Implementation of clinical sequencing for molecular profiling in patients with advanced cancer. Cancer biomarkers : section A of Disease markers 2021 Apr . Fukui Tomoya, Sakai Kazuko, Sasaki Jiichiro, Kakegawa Mikiko Ishihara, Igawa Satoshi, Mitsufuji Hisashi, Takeda Masayuki, Takahama Takayuki, Nakagawa Kazuhiko, Nishio Kazuto, Naoki Katsuhi |
| MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapy. Lung cancer (Amsterdam, Netherlands) 2021 Apr 154 142-145. Wong Selina K, Alex Deepu, Bosdet Ian, Hughesman Curtis, Karsan Aly, Yip Stephen, Ho Cher |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients with Non-Small Cell Lung Cancer. Chest 2021 Apr . Roosan Moom R, Mambetsariev Isa, Pharaon Rebecca, Fricke Jeremy, Husain Hatim, Reckamp Karen L, Koczywas Marianna, Massarelli Erminia, Bild Andrea H, Salgia Ra |
| Crizotinib in Patients With MET-Amplified NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Mar . Camidge D Ross, Otterson Gregory A, Clark Jeffrey W, Ignatius Ou Sai-Hong, Weiss Jared, Ades Steven, Shapiro Geoffrey I, Socinski Mark A, Murphy Danielle A, Conte Umberto, Tang Yiyun, Wang Sherry C, Wilner Keith D, Villaruz Liza |
| PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors. Clinical lung cancer 2021 Feb . Ferrara Miriam Grazia, Martini Maurizio, D'Argento Ettore, Forcella Chiara, Vita Emanuele, Di Noia Vincenzo, Sperduti Isabella, Bilotta Mirna, Ribelli Marta, Damiano Paola, Cannella Antonella, Stefani Alessio, Pilotto Sara, Carbone Carmine, Piro Geny, Milella Michele, Tortora Giampaolo, Bria Emil |
| [A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2021 Jan . Zhang Hui, Yang Xinjie, Li Kun, Wang Jinghui, Lv Jialin, Li Xi, Zhang Xinyong, Qin Na, Zhang Quan, Wu Yuhua, Ma Li, Gai Fei, Hu Ying, Zhang Shuc |
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
| The Clinical Impact of Capmatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification. Cancer research and treatment 2021 Jan . Choi Wonyoung, Park Seog-Yun, Lee Youngjoo, Lim Kun Young, Park Minjoung, Lee Geon Kook, Han Ji-Yo |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| The landscape of kinase domain duplication in Chinese lung cancer patients. Annals of translational medicine 2020 Dec 8 (24): 1642. Wu Di, Xie Yuancai, Jin Chang'e, Qiu Jinfan, Hou Ting, Du Haiwei, Chen Songan, Xiang Jianxing, Shi Xi, Liu Junli |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
| Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction. Lung cancer (Amsterdam, Netherlands) 2020 Nov . Kunimasa Kei, Oka Toru, Hara Satoshi, Yamada Noriyuki, Oizumi Satoshi, Miyashita Yoshihiro, Kamada Risa, Funamoto Tomoya, Kawachi Hayato, Kawamura Takahisa, Inoue Takako, Kuhara Hanako, Tamiya Motohiro, Nishino Kazumi, Matsunaga Takashi, Imamura Fumio, Fujita Masashi, Kumagai To |
| Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Oct . Yu Helena A, Paz-Ares Luis G, Yang James Chih-Hsin, Lee Ki Hyeong, Garrido Pilar, Park Keunchil, Kim Joo-Hang, Lee Dae Ho, Mao Huzhang, Wijayawardana Sameera R, Gao Ling, Hozak Rebecca R, Chao Bo H, Planchard Dav |
| Association between the combined effects of GSTM1 present/null and CYP1A1 MspI polymorphisms with lung cancer risk: an updated meta-analysis. Bioscience reports 2020 Sep . Zhang Wen-Ping, He Xiao-Feng, Ye Xiang-H |
| Characteristics and response to crizotinib in lung cancer patients with MET amplification detected by next-generation sequencing. Lung cancer (Amsterdam, Netherlands) 2020 Sep 149 17-22. Li Jingwen, Wang Yue, Zhang Bo, Xu Jianlin, Cao Shuhui, Zhong H |
| Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases. JAMA network open 2020 Aug 3 (8): e209077. Li Yang-Si, Zheng Mei-Mei, Jiang Ben-Yuan, Tu Hai-Yan, Yang Jin-Ji, Zhang Xu-Chao, Wu Yi-Lo |
| Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers. Lung cancer (Amsterdam, Netherlands) 2020 Aug 148 113-121. Yang Haiyan, Zhou Zhen, Lin Li, Yang Mingxia, Li Chong, Li Ziming, Yu Xinmin, Lizaso Analyn, Han-Zhang Han, Li Bing, Xiang Jianxing, Mao Xinru, Xu Qinqin, Zhang Yongchang, Yang No |
| Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian). Journal of thoracic disease 2020 Jul 12 (7): 3776-3784. Izumi Motohiro, Suzumura Tomohiro, Ogawa Koichi, Matsumoto Yoshiya, Sawa Kenji, Yoshimoto Naoki, Tani Yoko, Watanabe Tetsuya, Kaneda Hiroyasu, Mitsuoka Shigeki, Asai Kazuhisa, Kawaguchi Tomo |
| Impact of Somatic Mutations in Non-Small-Cell Lung Cancer: A Retrospective Study of a Chinese Cohort. Cancer management and research 2020 12 7427-7437. Shen Hai-Bo, Li Jie, Yao Yuan-Shan, Yang Zhen-Hua, Zhou Yin-Jie, Chen Wei, Hu Tian-J |
- Page last reviewed:Oct 1, 2021
- Page last updated:Oct 20, 2021
- Content source: